CRESCO LABS INC - CRLBF STOCK NEWS

Cresco Labs Inc. reports strong financial performance in Q4 2023 with revenue of $188 million and a 12% increase in adjusted gross profit. The company achieved a 3x improvement in full-year Operating Cash Flow and retained the No. 1 share position in key markets. However, there was a 2% decline in revenue due to strategic divestitures. Fiscal Year 2023 highlights include revenue of $771 million, adjusted EBITDA of $174 million, and a net loss of $180 million. The company's focus on the Year-of-the-Core strategy led to margin expansion and positive free cash flow.

Cresco Labs Inc. announces the reporting of financial results for Q4 and year-end 2023, along with a conference call and webcast to discuss business highlights.

Cresco Labs Inc. opens Sunnyside Gettysburg store in Pennsylvania, expanding its presence in the state. The new location offers a variety of cannabis products to qualified patients and caregivers.

Cresco Labs Inc. announces the transfer of Super Voting Shares among directors, enhancing balance and voting power within the company.

Cresco Labs Inc. announces the promotion of Greg Butler to President, overseeing all aspects of operations. Butler's experience in leading large iconic brands and his contributions to the development of Cresco Labs are highlighted. The company expresses confidence in its preparedness for the future of the cannabis industry.

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) reports strong margin and operating cash flow gains, eliminating over $40 million in annualized operating costs. Third quarter revenue reached $191 million, with adjusted gross margin increased by over 480 bps, and adjusted EBITDA margin rose by over 1000 bps. The company retained the No. 1 share position in Illinois, Pennsylvania, and Massachusetts, maintaining the industry's No. 1 bestselling portfolio of branded flower and branded concentrates.

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) issued a statement on Ohio's adult-use cannabis legalization, marking the 24th state to do so. The company lauds the move and anticipates a significant impact on the U.S. cannabis market, which is projected to exceed $100 billion annually. Cresco Labs plans to expand its Sunnyside dispensaries and distribution of cannabis brands in Ohio.

Cresco Labs, the industry leader in branded cannabis products, will report financial results for the third quarter of 2023 on November 15th. The company will host a conference call and webcast to discuss its financial results and provide key business highlights.

Cresco Labs announces the closing of the sale of its Arizona operation and secures a conventional mortgage on its New York properties.